Literature DB >> 6345399

Isolation and characterization of monoclonal antibodies to Shiga toxin.

D E Griffin, M K Gentry, J E Brown.   

Abstract

Hybridoma cell lines which produce monoclonal antibodies to Shiga toxin from Shigella dysenteriae 1 were prepared. The monoclonal antibodies were all of the immunoglobulin G1 isotype and differed in their ability to neutralize cytotoxicity and to bind to Shiga toxin in a solid-phase radioimmunoassay. When used for immunoblot analysis, these antibodies were able to identify specifically both nicked and unnicked Shiga toxin in crude lysates of S. dysenteriae.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345399      PMCID: PMC264798          DOI: 10.1128/iai.41.1.430-433.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  Inhibition of protein synthesis in intact HeLa cells by Shigella dysenteriae 1 toxin.

Authors:  J E Brown; S W Rothman; B P Doctor
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

2.  EPITHELIAL CELL PENETRATION AS AN ESSENTIAL STEP IN THE PATHOGENESIS OF BACILLARY DYSENTERY.

Authors:  E H Labrec; H Schneider; T J Magnani; S B Formal
Journal:  J Bacteriol       Date:  1964-11       Impact factor: 3.490

3.  Interaction of Shigella shigae cytotoxin with receptors on sensitive and insensitive cells.

Authors:  K Eiklid; S Olsnes
Journal:  J Recept Res       Date:  1980

4.  Inhibition of protein synthesis by Shiga toxin: activation of the toxin and inhibition of peptide elongation.

Authors:  J E Brown; M A Ussery; S H Leppla; S W Rothman
Journal:  FEBS Lett       Date:  1980-08-11       Impact factor: 4.124

5.  Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins.

Authors:  A D O'Brien; G D Laveck
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

6.  Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.

Authors:  J E Brown; D E Griffin; S W Rothman; B P Doctor
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

7.  Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography.

Authors:  A D O'Brien; G D LaVeck; D E Griffin; M R Thompson
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

8.  Quantitative microtiter cytotoxicity assay for Shigella toxin.

Authors:  M K Gentry; J M Dalrymple
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

9.  The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I.

Authors:  G T Keusch; G F Grady; L J Mata; J McIver
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

10.  The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit.

Authors:  R Reisbig; S Olsnes; K Eiklid
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

View more
  12 in total

1.  Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.

Authors:  L P Perera; J E Samuel; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

2.  Mutational analysis of the Shiga toxin and Shiga-like toxin II enzymatic subunits.

Authors:  M P Jackson; R L Deresiewicz; S B Calderwood
Journal:  J Bacteriol       Date:  1990-06       Impact factor: 3.490

3.  Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits.

Authors:  M Bielaszewska; I Clarke; M A Karmali; M Petric
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

Review 4.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

5.  Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis.

Authors:  M P Jackson; E A Wadolkowski; D L Weinstein; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

6.  Monoclonal antibody to Shiga toxin 2 which blocks receptor binding and neutralizes cytotoxicity.

Authors:  H Nakao; N Kiyokawa; J Fujimoto; S Yamasaki; T Takeda
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

7.  Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli.

Authors:  N A Strockbine; L R Marques; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

8.  Minimum domain of the Shiga toxin A subunit required for enzymatic activity.

Authors:  J E Haddad; A Y al-Jaufy; M P Jackson
Journal:  J Bacteriol       Date:  1993-08       Impact factor: 3.490

9.  Analysis of Shiga toxin subunit association by using hybrid A polypeptides and site-specific mutagenesis.

Authors:  C Jemal; J E Haddad; D Begum; M P Jackson
Journal:  J Bacteriol       Date:  1995-06       Impact factor: 3.490

10.  Cytotoxicity of a shiga toxin A subunit-CD4 fusion protein to human immunodeficiency virus-infected cells.

Authors:  A Y al-Jaufy; J E Haddad; S R King; R A McPhee; M P Jackson
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.